Crossmark

Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes

Crossref DOI link: https://doi.org/10.1007/s13346-024-01784-7

Published Online: 2025-01-24

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Didamoony, Manar A.

Soubh, Ayman A.

Ahmed, Lamiaa A. https://orcid.org/0000-0003-3476-2815
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2025-01-24

Version of Record valid from 2025-01-24
More Information

Article History

Accepted: 26 December 2024

First Online: 24 January 2025

Declarations

:

: There are no animal experiments carried out for this article.

: All authors agree to publish this article in Drug Delivery and Translational Research.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below